1386 - Gastric Contractility Modulation (GCM) therapy for patients with Type 2 Diabetes with Obesity (DIAMOND™ system Funding Application)

Page last updated: 11 July 2016

Application Detail

Status

Closed

Description of Medical Service

Laparoscopic placement of the Implantable Pulse Generator and Charge Coil with three pairs of Ultraflex gastric leads for treatment of Type 2 Diabetes with obesity to improve glycaemic control and induce weight loss.

Description of Medical Condition

Patients with Type 2 Diabetes with obesity who are inadequately controlled on standard oral glucose lowering (anti-diabetic) therapy.

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Comment on the Draft protocol closed at 11:59pm on 14 November 2014
Unratified Draft Protocol (PDF 500 KB)
Unratified Draft Protocol (Word 292 KB)

Feedback and Survey Form (PDF 70 KB)
Feedback and Survey Form (Word 45 KB)

Final Protocol (PDF 660 KB)
Final Protocol (Word 875 KB)

Assessment Report

-

Public Summary Document

Public Summary Document Application No. 1386 – gastric contractility modulation (GCM) therapy for patients with type 2 diabetes and obesity (PDF 216 KB)
Public Summary Document Application No. 1386 – gastric contractility modulation (GCM) therapy for patients with type 2 diabetes and obesity (Word 255 KB)

Meetings for this Application

PASC

11 to 12 December 2014

ESC

11 to 12 June 2015

MSAC

30 to 31 July 2015